As a result, inhibition of AKT-signaling pathway effectively sensitized STS and GIST to DNA-damaging agent, doxorubicin, and decreased tumor cell viability due by enhancing of apoptotic cell death (Figure 1 and Figure 2, Figures S3 and S4). The gene discussed is AKT1; the disease is gastrointestinal stromal tumor.